These suggest that T1D-protective HLA-B allomorphs undergo tapasin-mediated peptide optimization, while T1D-predisposing allotypes may proceed to the cell surface binding suboptimal peptides. The gene discussed is HLA-B; the disease is type 1 diabetes mellitus.